Results for tag: "Thrombophilia Drug"

The Thrombophilia Drug market is a subset of the Hematological Drugs market, which focuses on the treatment of blood-related disorders. Thrombophilia Drugs are used to treat thrombophilia, a condition in which the blood has an increased tendency to form clots. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a vein or artery. Commonly used Thrombophilia Drugs include anticoagulants, antiplatelet agents, and fibrinolytic agents. Anticoagulants are used to prevent the formation of clots, while antiplatelet agents are used to prevent the formation of clots in the arteries. Fibrinolytic agents are used to dissolve existing clots. Some companies in the Thrombophilia Drug market include Pfizer, Sanofi, Bayer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more